Grow Your Pharma Business Digitally
Market Place
Post Enquiry
Company
01 Gowling WLG (Canada) LLP (3)
Patent
01 2550361 (1)
02 2613015 (1)
03 2738573 (1)
Product
01 Vemurafenib (3)
Dosage
01 Tablet (3)
Exp Date
01 2024-12-17 (1)
02 2026-06-21 (1)
03 2030-03-31 (1)